Market closed
Upstream Bio, Inc./$UPB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Upstream Bio, Inc.
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
Ticker
$UPB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
52
Website
UPB Metrics
BasicAdvanced
$327M
-
-$4.59
-
-
Price and volume
Market cap
$327M
52-week high
$10.08
52-week low
$5.59
Financial strength
Current ratio
44.627
Quick ratio
43.926
Long term debt to equity
0.241
Total debt to equity
0.39
Management effectiveness
Return on assets (TTM)
-16.23%
Return on equity (TTM)
-21.74%
Valuation
Price to revenue (TTM)
35.216
Price to book
0.7
Price to tangible book (TTM)
0.7
Price to free cash flow (TTM)
-1.398
Growth
Revenue change (TTM)
-0.42%
Earnings per share change (TTM)
-56.89%
UPB News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Upstream Bio, Inc. stock?
Upstream Bio, Inc. (UPB) has a market cap of $327M as of April 08, 2025.
What is the P/E ratio for Upstream Bio, Inc. stock?
The price to earnings (P/E) ratio for Upstream Bio, Inc. (UPB) stock is 0 as of April 08, 2025.
Does Upstream Bio, Inc. stock pay dividends?
No, Upstream Bio, Inc. (UPB) stock does not pay dividends to its shareholders as of April 08, 2025.
When is the next Upstream Bio, Inc. dividend payment date?
Upstream Bio, Inc. (UPB) stock does not pay dividends to its shareholders.
What is the beta indicator for Upstream Bio, Inc.?
Upstream Bio, Inc. (UPB) does not currently have a Beta indicator.